|
|
|
|
LEADER |
03333nam a2200601Ia 4500 |
001 |
10.3390-molecules27072183 |
008 |
220425s2022 CNT 000 0 und d |
020 |
|
|
|a 14203049 (ISSN)
|
245 |
1 |
0 |
|a Calceolarioside A, a Phenylpropanoid Glycoside from Calceolaria spp., Displays Antinociceptive and Anti-Inflammatory Properties
|
260 |
|
0 |
|b MDPI
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3390/molecules27072183
|
520 |
3 |
|
|a Phenylpropanoid glycosides are a class of natural substances of plant origin with interesting biological activities and pharmacological properties. This study reports the antinociceptive and anti-inflammatory effects of calceolarioside A, a phenylpropanoid glycoside previously isolated from various Calceolaria species. In models of acute nociception induced by thermal stimuli, such as the hot plate and tail flick test, calceolarioside administered at doses of 1, 5, and 10 µg in the left cerebral ventricles did not modify the behavioral response of mice. In an inflammatory based persistent pain model as the formalin test, calceolarioside A at the high dose tested (100 µg/paw) reduced the licking activity induced by formalin by 35% in the first phase and by 75% in the second phase of the test. In carrageenan-induced thermal hyperalgesia, calceolarioside A (50 and 100 µg/paw) was able to significantly reverse thermal hyperalgesia induced by carrageenan. The anti-inflammatory activity of calceolarioside A was then assessed using the zymosan-induced paw edema model. Calceolarioside A (50 and 100 µg/paw) induced a significant reduction in the edema from 1 to 4 h after zymosan administration. Measuring IL-6, TNFα, and IL-1β pro-inflammatory cytokines released from LPS-stimulated THP-1 cells, calceolarioside A in a concentration-dependent manner reduced the release of these cytokines from THP-1 cells. Taken together, our results highlight, for the first time, the potential and selective anti-inflammatory properties of this natural-derived compound, prompting its rationale use for further investigations. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
|
650 |
0 |
4 |
|a analgesic agent
|
650 |
0 |
4 |
|a Analgesics
|
650 |
0 |
4 |
|a animal
|
650 |
0 |
4 |
|a Animals
|
650 |
0 |
4 |
|a antiinflammatory agent
|
650 |
0 |
4 |
|a Anti-Inflammatory Agents
|
650 |
0 |
4 |
|a caffeic acid derivative
|
650 |
0 |
4 |
|a Caffeic Acids
|
650 |
0 |
4 |
|a Calceolaria
|
650 |
0 |
4 |
|a Calceolariaceae
|
650 |
0 |
4 |
|a Calceolariaceae
|
650 |
0 |
4 |
|a calceolarioside A
|
650 |
0 |
4 |
|a calceolarioside A
|
650 |
0 |
4 |
|a carrageenan
|
650 |
0 |
4 |
|a Carrageenan
|
650 |
0 |
4 |
|a edema
|
650 |
0 |
4 |
|a Edema
|
650 |
0 |
4 |
|a glucoside
|
650 |
0 |
4 |
|a Glucosides
|
650 |
0 |
4 |
|a glycoside
|
650 |
0 |
4 |
|a Glycosides
|
650 |
0 |
4 |
|a hyperalgesia
|
650 |
0 |
4 |
|a Hyperalgesia
|
650 |
0 |
4 |
|a inflammation
|
650 |
0 |
4 |
|a Mice
|
650 |
0 |
4 |
|a mouse
|
650 |
0 |
4 |
|a nociception
|
650 |
0 |
4 |
|a pain
|
650 |
0 |
4 |
|a Pain
|
650 |
0 |
4 |
|a phenylpropanoid glycosides
|
650 |
0 |
4 |
|a plant extract
|
650 |
0 |
4 |
|a Plant Extracts
|
650 |
0 |
4 |
|a zymosan
|
650 |
0 |
4 |
|a Zymosan
|
700 |
1 |
|
|a Aloisi, A.M.
|e author
|
700 |
1 |
|
|a Mollica, A.
|e author
|
700 |
1 |
|
|a Nicoletti, M.
|e author
|
700 |
1 |
|
|a Pieretti, S.
|e author
|
700 |
1 |
|
|a Saviano, A.
|e author
|
700 |
1 |
|
|a Stefanucci, A.
|e author
|
773 |
|
|
|t Molecules
|